Limited T-cell presence despite extensive microglial HLA class II expression in the frontal cortex in Alzheimer’s disease

The human brain is not an isolated fortress; it maintains a constant, quiet dialogue with the immune system, the body's defense force. For decades, scientists have known that in Alzheimer's disease, the brain's own immune cells, called microglia, become highly active. These cells act like microscopic sentinels, constantly scanning for trouble. A key sign of this activity is the appearance of a specific marker on their surface, known as HLA class II. In the language of immunology, this marker is a flag that says, "I am ready to show a piece of a problem to a specialized soldier called a T cell." When a T cell sees this flag, it is supposed to jump into action, multiply, and help fight the threat. Because these flags are so abundant in the brains of people with Alzheimer's, many researchers assumed that a massive army of T cells must be present, swarming the brain tissue to fight the disease. This assumption has shaped how scientists think about the disease, suggesting that the immune system is in a state of full-scale war within the brain.

However, a new study challenges this picture of a crowded battlefield. Researchers from Belgium and Germany set out to count the actual soldiers on the ground, rather than just looking for the flags. They examined brain tissue from the frontal cortex, the area behind the forehead responsible for thinking and planning, from people who had died with Alzheimer's disease. They also looked at tissue from people who died without dementia. Using a technique that stains specific cells with different colors, they counted the microglia displaying the HLA class II flag and compared that number to the actual T cells found in the same tissue. They also included a case of a different, severe brain inflammation called acute disseminated encephalomyelitis, where the immune system is known to be in a frenzy, to ensure their counting method could actually see the soldiers if they were there.

The results revealed a striking and unexpected gap between the signal and the response. In the brains of people with Alzheimer's, the researchers found a vast number of microglia displaying the HLA class II flag. On average, they counted about 18,000 of these flagged cells in every square centimeter of brain tissue. Yet, when they looked for the T cells that these flags were meant to attract, they found very few. In the same area, there were only about eight T cells per square centimeter. This ratio is immense; for every single T cell present, there were thousands of microglia waving their flags. The researchers found that the number of T cells in the Alzheimer's brains was not significantly higher than in the brains of people without dementia. In fact, the T cells were so sparse that they appeared as isolated, rare visitors rather than an invading force.

To confirm that their method was not simply missing the cells, the team examined the tissue from the patient with acute disseminated encephalomyelitis. In that case, the method worked perfectly, revealing dense clusters of thousands of T cells per square centimeter, exactly as expected for a severe inflammatory disease. This comparison proved that the lack of T cells in the Alzheimer's brains was a real biological finding, not a failure of the technology. The study also looked at different types of T cells, including those that help the immune response and those that kill infected cells. Both types were rare, though the killing cells were slightly more common than the helpers. Even so, their numbers remained tiny compared to the sea of microglia.

The researchers also checked if the few T cells that were present were clustered near the hallmark plaques of Alzheimer's, which are sticky clumps of protein that build up in the brain. They found that while the microglia with the flags were often gathered around these plaques, the T cells were not. The T cells were scattered randomly throughout the tissue, showing no specific pattern of gathering near the disease's most obvious signs. This suggests that the microglia are not necessarily interacting with these rare T cells in the way previously thought. Instead of a coordinated battle, the scene looks more like a vast number of sentinels standing ready, while the soldiers they are meant to call are largely absent from the immediate area.

This discovery forces a rethinking of how the immune system behaves in Alzheimer's disease. The presence of the HLA class II flag on microglia does not automatically mean that a large army of T cells is engaged in a fight within the brain tissue. The study indicates that the immune response in Alzheimer's may be different from what is seen in other inflammatory conditions. The microglia might be displaying these flags for reasons other than recruiting a massive T cell invasion, perhaps as part of a broader, more subtle form of surveillance or regulation. While a small number of T cells are present, their scarcity suggests they are not the primary drivers of the widespread immune activity seen in the brain. The findings do not rule out that these few cells have some effect, but they make it clear that the immune landscape of Alzheimer's is not defined by a dense infiltration of T cells.

The study concludes that scientists should be careful not to assume that the presence of immune markers equals a massive immune cell presence. The brain in Alzheimer's disease shows a complex picture where the immune system is active, but not necessarily in the way of a full-scale war with an invading army. The next step for researchers is to understand what these rare T cells are actually doing and why the microglia are so active without them. This work highlights the importance of looking at the actual cells in the tissue rather than relying solely on genetic signals that suggest what might be happening. By counting the real cells, the researchers have provided a clearer, more grounded view of the immune environment in Alzheimer's, showing that the story of the disease is more nuanced than a simple battle between microglia and T cells.